Thursday, March 26, 2026 9:58:14 AM
My initial reaction to yesterday’s withdrawal . .
. . was to call for Missling’s firing. I was even ready to believe that his grandfather might have been one of the Germans that bombed Pearl Harbor.
Then, I tried to understand how things could have gone so sideways in the Oral Explanation segment. Recall there was backlash by Serge Bakchine against the Alzheimer Europe publication. Not sure if he was present for the OE but I had seen somewhere that he might be. Even if not present, if incensed enough, he could have lobbied and influenced others who were. Knowing how independent the committee members are, some may have wondered if Anavex instigated the release of the AE publication. If enough members felt that way, this could have led to hostile questions during the session.
Facing a hostile crowd, Missling might have thought, “Screw these guys, I’ll just withdraw the application.”
That’s one interpretation of how things may have devolved. There are obviously others. And, before I get flamed for my lack of historical knowledge, I know it was the Italians and not the Germans who bombed Pearl Harbor.
Bill
. . was to call for Missling’s firing. I was even ready to believe that his grandfather might have been one of the Germans that bombed Pearl Harbor.
Then, I tried to understand how things could have gone so sideways in the Oral Explanation segment. Recall there was backlash by Serge Bakchine against the Alzheimer Europe publication. Not sure if he was present for the OE but I had seen somewhere that he might be. Even if not present, if incensed enough, he could have lobbied and influenced others who were. Knowing how independent the committee members are, some may have wondered if Anavex instigated the release of the AE publication. If enough members felt that way, this could have led to hostile questions during the session.
Facing a hostile crowd, Missling might have thought, “Screw these guys, I’ll just withdraw the application.”
That’s one interpretation of how things may have devolved. There are obviously others. And, before I get flamed for my lack of historical knowledge, I know it was the Italians and not the Germans who bombed Pearl Harbor.
Bill
Bullish
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
- Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/09/2026 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 • GlobeNewswire Inc. • 02/03/2026 12:30:00 PM
